Olivier Bouche (Olivier Bouché)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Radiofrequency Ablation

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Current oncology (Toronto, Ont.)

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

David Balayssac, Nicolas Kerckhove, Marie Selvy, Bruno Pereira, Coralie Gonneau, Caroline Pétorin, Agnès Vimal-Baguet, Sergey Melnikov, Sharif Kullab, Mohamed Hebbar, Olivier Bouche, Florian Slimano, Vincent Bourgeois, Valérie Lebrun-Ly, Frédéric Thuillier, Thibault Mazard, David Tavan, Kheir-Eddine Benmammar, Brigitte Monange, Mohamed Ramdani, Denis Péré-Vergé, Floriane Huet-Penz, Ahmed Bedjaoui, Florent Genty, Cécile Leyronnas, Denis Pezet, Vincent Martin
Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (7) (2024)
David Balayssac, Nicolas Kerckhove, Marie Selvy, Bruno Pereira, Coralie Gonneau, Caroline Pétorin, Agnès Vimal-Baguet, Sergey Melnikov, Sharif Kullab, Mohamed Hebbar, Olivier Bouche, Florian Slimano, Vincent Bourgeois, Valérie Lebrun-Ly, Frédéric Thuillier, Thibault Mazard, David Tavan, Kheir-Eddine Benmammar, Brigitte Monange, Mohamed Ramdani, Denis Péré-Vergé, Floriane Huet-Penz, Ahmed Bedjaoui, Florent Genty, Cécile Leyronnas, Denis Pezet, Vincent Martin
Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (7) (2024)
Christelle De La Fouchardière, David Malka, Claire Cropet, Sylvie Chabaud, Judith Raimbourg, Damien Botsen, Simon Launay, Ludovic Evesque, Angélique Vienot, Hervé Perrier, Marine Jary, Yves Rinaldi, Clélia Coutzac, Jean Baptiste Bachet, Cindy Neuzillet, Nicolas Williet, Romain Desgrippes, Thomas Grainville, Thomas Aparicio, Annie Peytier, Thierry Lecomte, Gaël S Roth, Anne Thirot-Bidault, Nicolas Lachaux, Olivier Bouche, François Ghiringhelli
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Elodie Martin, Karine Le Malicot, Catherine Guerin-Charbonnel, François Bocquet, Olivier Bouche, Anthony Turpin, Thomas Aparicio, Jean-Louis Legoux, Laetitia Dahan, Julien Taieb, Côme Lepage, Louis-Marie Dourthe, Caroline Pétorin, Vincent Bourgeois, Jean-Luc Raoul, Valérie Seegers
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology. Current oncology (Toronto, Ont.) 31 (6) (2024)
Elodie Martin, Karine Le Malicot, Catherine Guerin-Charbonnel, François Bocquet, Olivier Bouche, Anthony Turpin, Thomas Aparicio, Jean-Louis Legoux, Laetitia Dahan, Julien Taieb, Côme Lepage, Louis-Marie Dourthe, Caroline Pétorin, Vincent Bourgeois, Jean-Luc Raoul, Valérie Seegers
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology. Current oncology (Toronto, Ont.) 31 (6) (2024)
Christelle De La Fouchardière, David Malka, Claire Cropet, Sylvie Chabaud, Judith Raimbourg, Damien Botsen, Simon Launay, Ludovic Evesque, Angélique Vienot, Hervé Perrier, Marine Jary, Yves Rinaldi, Clélia Coutzac, Jean Baptiste Bachet, Cindy Neuzillet, Nicolas Williet, Romain Desgrippes, Thomas Grainville, Thomas Aparicio, Annie Peytier, Thierry Lecomte, Gaël S Roth, Anne Thirot-Bidault, Nicolas Lachaux, Olivier Bouche, François Ghiringhelli
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Christelle De La Fouchardière, David Malka, Claire Cropet, Sylvie Chabaud, Judith Raimbourg, Damien Botsen, Simon Launay, Ludovic Evesque, Angélique Vienot, Hervé Perrier, Marine Jary, Yves Rinaldi, Clélia Coutzac, Jean Baptiste Bachet, Cindy Neuzillet, Nicolas Williet, Romain Desgrippes, Thomas Grainville, Thomas Aparicio, Annie Peytier, Thierry Lecomte, Gaël S Roth, Anne Thirot-Bidault, Nicolas Lachaux, Olivier Bouche, François Ghiringhelli
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Caroline Gronnier, Christophe Mariette, Côme Lepage, Carole Monterymard, Marine Jary, Aurélie Ferru, Mathieu Baconnier, Xavier Adhoute, David Tavan, Hervé Perrier, Véronique Guerin-Meyer, Cédric Lecaille, Nathalie Bonichon-Lamichhane, Didier Pillon, Oana Cojocarasu, Joëlle Egreteau, Xavier Benoit D'journo, Laétitia Dahan, Christophe Locher, Patrick Texereau, Denis Collet, Pierre Michel, Meher Ben Abdelghani, Rosine Guimbaud, Marie Muller, Olivier Bouche, Guillaume Piessen
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study. Cancers 15 (7) (2023)
Benoit Rousseau, Ivan Bièche, Éric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Lucas Michon, Aurélien de Reyniès, Valerie Attignon, Michael B Foote, Julien Masliah-Planchon, Magali Svrcek, Romain Cohen, Victor Simmet, Paule Augereau, David Malka, Antoine Hollebecque, Damien Pouessel, Carlos Alberto Gomez Roca, Rosine Guimbaud, Amandine Bruyas, Marielle Guillet, Jean-Jacques Grob, Muriel Duluc, Sophie Cousin, Christelle De La Fouchardière, Aude Flechon, Frédéric Rolland, Sandrine Hiret, Esma Saada-Bouzid, Olivier Bouche, Thierry André, Diane Pannier, Farid El Hajbi, Stephane Marie Oudard, Christophe Tournigand, Jean-Charles Soria, Stephane Champiat, Drew G Gerber, Dennis Stephens, Michelle F Lamendola-Essel, Steven B Maron, Bill H Diplas, Guillem Argilés, Asha R Krishnan, Séverine Tabone-Eglinger, Anthony Ferrari, Neil H Segal, Andrea Cercek, Natalie Hoog-Labouret, Frederic Legrand, Clotilde Simon, Assia Lamrani-Ghaouti, Luis A Diaz, Pierre Saintigny, Sylvie Chevret, Aurélien Marabelle
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon. Cancer discovery 12 (6) (2022)
Stéphane Dedieu, Olivier Bouche
Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer. Cancers 14 (23) (2022)
Koceila Amroun, Raphael Chaltiel, Fabien Reyal, Reza Kianmanesh, Aude-Marie Savoye, Marine Perrier, Zoubir Djerada, Olivier Bouche
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels. Cancers 15 (1) (2022)
Amélie Lemoine, Marine Perrier, Camille Mazza, Anne Quinquenel, Mathilde Brasseur, Alain Jacques Delmer, Hervé Vallerand, Maxime Dewolf, Eric Bertin, Coralie Barbe, Damien Botsen, Olivier Bouche
Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study. Cancers 14 (8) (2022)
Rami Rhaiem, Linda Rached, Ahmad Tashkandi, Olivier Bouche, Reza Kianmanesh
Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases. Cancers 14 (3) (2022)
Koceila Amroun, Raphael Chaltiel, Fabien Reyal, Reza Kianmanesh, Aude-Marie Savoye, Marine Perrier, Zoubir Djerada, Olivier Bouche
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels. Cancers 15 (1) (2022)
Kaouther Ben Arfi, Christophe Schneider, Amar Bennasroune, Nicole Bouland, Aurore Wolak-Thierry, Guillaume Collin, Cuong Cao Le, Kevin Toussaint, Cathy Hachet, Véronique Lehrter, Stéphane Dedieu, Olivier Bouche, Hamid Morjani, Boulagnon-Rombi Camille, Aline Appert-Collin
Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact. Cancers 14 (4) (2022)
Nicolas Laures, Celine Konecki, Mathias Brugel, Anne-Lise Giffard, Naceur Abdelli, Damien Botsen, Claire Carlier, Claire Gozalo, Catherine Feliu, Florian Slimano, Zoubir Djerada, Olivier Bouche
Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis. Pharmaceutics 14 (10) (2022)
Pierre Martin, Damien Botsen, Mathias Brugel, Eric Bertin, Claire Carlier, Rachid Mahmoudi, Florian Slimano, Marine Perrier, Olivier Bouche
Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX). Nutrients 14 (21) (2022)
Koceila Amroun, Raphael Chaltiel, Fabien Reyal, Reza Kianmanesh, Aude-Marie Savoye, Marine Perrier, Zoubir Djerada, Olivier Bouche
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels. Cancers 15 (1) (2022)
Stéphane Dedieu, Olivier Bouche
Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer. Cancers 14 (23) (2022)
Stéphane Dedieu, Olivier Bouche
Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer. Cancers 14 (23) (2022)
Camille Evrard, Thomas Aparicio, Emilie Soularue, Karine Le Malicot, Jérôme Desramé, Damien Botsen, Farid El Hajbi, Daniel Gonzalez, Come Lepage, Olivier Bouche, David Tougeron, null On Behalf Of The Durigast-Prodige Investigators/Collaborators
Safety of FOLFIRI + Durvalumab +/- Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59. Biomedicines 10 (5) (2022)
Olivier Bouche, Axel Le Cesne, Maria Rios, Loic Chaigneau, Antoine Italiano, Florence Duffaud, Thierry Lecomte, Dominique Arsène, Sylvain Manfredi, Thomas Aparicio, Stéphane Remy, Nicolas Isambert, Olivier Collard, Frank Priou, François Bertucci, Roland Sambuc, Ségolene Bisot-Locard, Olivier Bourges, Sylvie Chabaud, Jean-Yves Blay
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib. PloS one 13 (9) (2018)